BERLIN (Reuters) - Biotech firm GNA Biosolutions said on Tuesday it has received emergency use approval from German's health authority for its quick COVID-19 test that it says is as reliable as widely ...
GNA Biosolutions GmbH will be showcasing the Pharos V8, the world’s first Laser PCR instrument based on the company’s proprietary Pulse Controlled Amplification (PCA) technology at the Analytica trade ...
Molecular testing for tuberculosis (TB) could one day take only a few minutes, according to scientists behind a new €3.8 million project. Molecular technology company GNA Biosolutions GmbH and its ...
GNA Biosolutions employs small heaters within its consumables to modulate sample temperature in short pulses, allowing for portable, battery-operated devices. (Rawpixel) () GNA Biosolutions raised $13 ...
GNA Biosolutions GmbH, a German molecular diagnostics company, has secured $13.5 million in Series C financing. The investors included GreyBird Ventures, Occident, Wachtumsfonds Bayern, SHS ...
GNA Biosolutions GmbH will be showcasing the Pharos V8, the world’s first Laser PCR instrument based on the company’s proprietary Pulse Controlled Amplification (PCA) technology at the Analytica trade ...
INGELHEIM, Germany--(BUSINESS WIRE)--Boehringer Ingelheim and GNA Biosolutions announce that they have entered into a research collaboration focused on the development of a rapid African swine fever ...
Boehringer Ingelheim and GNA Biosolutions announced that they have entered into a research collaboration focused on the development of a rapid African swine fever (ASF) diagnostic test. The test would ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results